The performance evaluation of unassayed biochemistry serum controls
Ruilai Liu,Chen Zhang,Weiwei Lin,Hui Ding,Ming Guan
DOI: https://doi.org/10.3760/cma.j.issn.1009-9158.2019.09.013
2019-01-01
Abstract:Objective To evaluate the inter-bottle variations, stability in consumption and interchangeability of unassayed biochemistry serum controls. Methods Comparison between unassayed serum controls from a domestic "Pretrol?" and an international "Bio-Rad" manufacturer was conducted in department of laboratory, in May 2016, with Roche Cobas 8000, Roche Hitachi 7600 and Siemens 2400 modular analyzer. The inter-bottle variation was determined by monitoring the inter-batch variation of 10 bottles of control samples after eliminating the intra-batch variation from the same bottle. Stability in consumption was determined as the precision after 7 days storage under 2℃ to 8℃ or 30 days of storage under -20 ℃ since reconstitution. The interchangeability was determined as the precisionbetween the controls from different manufacturers for the same test. Results The inter-bottle imprecision of controls from domestic manufacturer for 13 biochemistry tests (CV concentration 1/CV concentration 2) were potassium (0.26％/0.42％), sodium (0.26％/0.21％), phosphorus (0.00％/0.62％), cholesterol (0.56％/0.54％), total protein (0.52％/0.33％), albumin (0.44％/2.00％), alanine aminotransferase (1.72％/0.57％),γ-glutamylaminotransferase (0.52％/0.62％), aspartate aminotransferase (3.10％/1.09％), lactate dehydrogenase (0.76％/0.91％), alkaline phosphatase (1.13％/0.97％), amylase (0.30％/0.39％) and glucose (0.00％/0.40％). The stability in consumption of the controls from the domestic manufacturer (CV concentration 1/CV concentration 2 under 2℃to 8℃storage;CV concentration 1/CV concentration 2 under-20℃ storage) were potassium (1.06％/0.36％; 0.74％/0.48％), sodium (0.49％/0.59％; 0.72％/0.65％), phosphorus (0.95％/0.80％;1.43％/0.84％), cholesterol (1.49％/1.58％;2.17％/1.80％), total protein (0.84％/0.75％; 1.60％/1.68％), albumin (1.33％/2.28％; 1.94％/2.43％), alanine aminotransferase (1.41％/0.51％;3.24％/1.60％) γ-glutamylaminotransferase (1.16％/1.16％; 2.85％/2.49％), aspartate aminotransferase (4.37％/2.14％; 2.99％/1.31％), lactate dehydrogenase (2.70％/2.54％; 3.84％/2.97％), alkaline phosphatase (2.63％/1.96％; 2.31％/2.10％), amylase (0.95％/2.19％; 1.58％/1.38％) and glucose (0.60％/0.48％; 1.41％/1.55％). The Inter-bottle variation and stability in consumption of biochemistry test unassayed controls from the domestic manufacturer were compatible for clinical assay according to the CV％ specification from the Clinical Biochemistry Test Quality Requirement (WS/T 403-2012). The imprecision of the controls from both the domestic and international manufacturers (CVp concentration 1/CVp concentration2;CVq concentration 1/CVq concentration 2) were potassium (0.52％/0.46％; 2.39％/0.47％), sodium (0.30％/0.17％; 0.81％/0.47％), phosphorus (2.72％/1.11％;4.57％/2.07％), cholesterol (0.29％/1.38％;2.94％/1.81％), total protein (0.66％/2.46％;1.85％/2.54％), alkaline phosphatase (2.67％/4.66％;3.58％/8.55％), total bilirubin (5.71％/5.09％; 9.55％/7.41％), albumin (1.10％/2.61％; 4.79％/1.93％), alanine aminotransferase (6.42％/1.25％;5.74％/1.63％), γ-glutamylaminotransferase (2.27％/4.35％; 4.38％/0.74％), aspartate aminotransferase (0.56％/2.84％; 0.91％/2.11％) and lactate dehydrogenase (2.36％/2.47％; 3.10％/1.52％). The interchangeability of serum controls from domestic manufacturer was better than clinical serum samples. Conclusion The unassayed serum biochemistry test controls from domestic manufacturer are suitable for the intra-laboratory quality control and showed a promising compatibility for inter-laboratory quality control usage .